Evidence map›Paper›PMID 22002579›Full record

ReviewCellular and molecular life sciences : CMLS2012

The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

H A Tejeda, T S Shippenberg, R Henriksson

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 1 synthesis or guideline pooled it, 160 citations in OpenAlex.

  1. Prodynorphin gene promoter polymorphism and temporal lobe epilepsy: A meta-analysis.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2015
    Pooled it
  2. Trial
  3. BLA kappa opioid receptor inputs to the BNST mediate social stress-induced increases in alcohol drinking.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Epigenetic mechanisms of HIV and opioid-induced neuropathology: Potential therapies and interventions.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. BLAbioRxiv : the preprint server for biology · 2024
    Article
  15. Self-DNA inMolecules (Basel, Switzerland) · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

H A TejedaIntegrative Neuroscience Section, Integrative Neuroscience Research Branch, NIDA-IRP, NIH, Baltimore, MD 21224, USA.
T S Shippenberg
R Henriksson
Karolinska Institutet · SE

Funding

Kappa-Opioid Receptor Mediated Regulation of Dopamine TransportR01MH083928 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI RAMAMOORTHY, SAMMANDA · 2010 to 2014
$1.7M
Intramural NIH HHSNIMH NIH HHS R01 MH083928NIMH NIH HHS R01MH083928
6 · The paper itself

Abstract

The dynorphin/κ-opioid receptor system has been implicated in the pathogenesis and pathophysiology of several psychiatric disorders. In the present review, we present evidence indicating a key role for this system in modulating neurotransmission in brain circuits that subserve mood, motivation, and cognitive function. We overview the pharmacology, signaling, post-translational, post-transcriptional, transcriptional, epigenetic and cis regulation of the dynorphin/κ-opioid receptor system, and critically review functional neuroanatomical, neurochemical, and pharmacological evidence, suggesting that alterations in this system may contribute to affective disorders, drug addiction, and schizophrenia. We also overview the dynorphin/κ-opioid receptor system in the genetics of psychiatric disorders and discuss implications of the reviewed material for therapeutics development.

Indexed as

BrainCentral Nervous System StimulantsCyclic AMP Response Element-Binding ProteinDynorphinsEnkephalinsEpigenesis, GeneticGene Expression RegulationHumansMental DisordersModels, AnimalProtein PrecursorsReceptors, Opioid, kappaSelf StimulationSignal TransductionCentral Nervous System StimulantsCREB1 protein, humanCyclic AMP Response Element-Binding ProteinDynorphinsEnkephalinsOPRK1 protein, humanpreproenkephalinProtein PrecursorsReceptors, Opioid, kappa

Identifiers

PMID22002579
PMCPMC11114766
OpenAlexW1992781596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.